Milla Koistinaho is a founder and a Board member of Aranda. Milla is a biotech commercialization professional with over 20 years of experience in commercializing early-stage biomedical inventions. After completing her PhD thesis in Neurosciences in cooperation with Silicon Valley based biopharmaceutical company and gaining postgraduate experience with Eli Lilly and Company she has co-founded 3 biotech start-ups based on her own academic discoveries. During her entrepreneurial years, she has gained deep experience in pharmaceutical discovery and development, IPR generation and prosecution, fundraising, out-licensing, and other corporate transactions. She has also served as the COO of technology transfer operations at the University of Helsinki, being responsible for the identification of inventions, managing the University’s patent portfolio, licensing, and spinning out companies arising from academic excellence. Milla Koistinaho is a founding partner of a new 90m EUR venture capital fund, Innovestor Life Science, which invests in Seed to Series A stage, strong health sciences-based companies in the Nordics and Baltics. Milla also holds several non-executive directorships in therapeutics development companies in the Nordics and serves as a member of the commercialization advisory board at the University of Helsinki.
